|
1
|
Brocklehurst PR, Baker SR and Speight PM:
Oral cancer screening: What have we learnt and what is there still
to achieve? Future Oncol. 6:299–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kessler P, Grabenbauer G, Leher A,
Bloch-Birkholz A, Vairaktaris E and Neukam FW: Neoadjuvant and
adjuvant therapy in patients with oral squamous cell carcinoma
long-term survival in a prospective, non-randomized study. Br J
Oral Maxillofac Surg. 46:1–5. 2008. View Article : Google Scholar
|
|
4
|
Gupta S, Kong W, Peng Y, Miao Q and
Mackillop WJ: Temporal trends in the incidence and survival of
cancers of the upper aerodigestive tract in Ontario and the United
States. Int J Cancer. 125:2159–2165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kapoor A and Kumar S: Cancer stem cell: A
rogue responsible for tumor development and metastasis. Indian J
Cancer. 51:282–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y, Jiang CQ and Fan LF: Correlation
of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal
adenocarcinomas. Tumour Biol. 36:6075–6082. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu XF, Yang WT, Xu R, Liu JT and Zheng
PS: Cervical cancer cells with positive Sox2 expression exhibit the
properties of cancer stem cells. PLoS One. 9:e870922014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu XS, Xi HQ and Chen L: Lgr5 is a
potential marker of colorectal carcinoma stem cells that correlates
with patient survival. World J Surg Oncol. 10:2442012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HY, Lin LT, Wang ML, Tsai KL, Huang
PI, Yang YP, Lee YY, Chen YW, Lo WL, Lan YT, et al: Musashi-1
promotes chemoresistant granule formation by PKR/eIF2α signalling
cascade in refractory glioblastoma. Biochim Biophys Acta Mol Basis
Di. 1864:1850–1861. 2018. View Article : Google Scholar
|
|
10
|
Gong P, Wang Y, Gao Y, Gao M, Liu L, Qu P,
Jin X and Gao Q: Msi1 promotes tumor progression by
epithelial-to-mesenchymal transition in cervical cancer. Hum
Pathol. 65:53–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guan A, Wang H, Li X, Xie H, Wang R, Zhu Y
and Li R: MiR-330-3p inhibits gastric cancer progression through
targeting MSI1. Am J Transl Res. 8:4802–4811. 2016.PubMed/NCBI
|
|
12
|
Liu L, Qiu F, Chen J, Wu D, Nong Q, Zhou Y
and Lu J: Functional polymorphism in the MSI1 gene promoter confers
a decreased risk of lung cancer in chinese by reducing MSI1
expression. Curr Genomics. 19:375–383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lang Y, Kong X, He C, Wang F, Liu B, Zhang
S, Ning J, Zhu K and Xu S: Musashi1 promotes non-small cell lung
carcinoma malignancy and chemoresistance via activating the Akt
signaling pathway. Cell Physiol Biochem. 44:455–466. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qin G, Lian J, Yue D, Chen X, Nan S, Qi Y,
Li B, Cui G, Li X, Zhao S and Zhang Y: Musashi1, a potential
prognostic marker in esophageal squamous cell carcinoma. Oncol Rep.
38:1724–1732. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dahlrot RH: The prognostic value of
clinical factors and cancer stem cell-related markers in gliomas.
Dan Med J. 61:B49442014.PubMed/NCBI
|
|
16
|
Moghbeli M, Forghanifard MM, Sadrizadeh A,
Mozaffari HM, Golmakani E and Abbaszadegan MR: Role of Msi1 and
MAML1 in regulation of notch signaling pathway in patients with
esophageal squamous cell carcinoma. J Gastrointest Cancer.
46:365–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pastò A, Serafin V, Pilotto G, Lago C,
Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G,
et al: NOTCH3 signaling regulates MUSASHI-1 expression in
metastatic colorectal cancer cells. Cancer Res. 74:2106–2118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
19
|
Niu J, Zhao X, Liu Q and Yang J: Knockdown
of MSI1 inhibited the cell proliferation of human osteosarcoma
cells by targeting p21 and p27. Oncol Lett. 14:5271–5278.
2017.PubMed/NCBI
|
|
20
|
Jadhav S, Ajay AK, Trivedi P, Seematti J,
Pellegrini K, Craciun F and Vaidya VS: RNA-binding protein Musashi
Homologue 1 regulates kidney fibrosis by translational inhibition
of p21 and Numb mRNA. J Biol Chem. 291:14085–14094. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abdelmohsen K, Srikantan S, Kuwano Y and
Gorospe M: miR-519 reduces cell proliferation by lowering
RNA-binding protein HuR levels. Proc Natl Acad Sci USA.
105:20297–20302. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Busà R, Paronetto MP, Farini D,
Pierantozzi E, Botti F, Angelini DF, Attisani F, Vespasiani G and
Sette C: The RNA-binding protein Sam68 contributes to proliferation
and survival of human prostate cancer cells. Oncogene.
26:4372–4382. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sutherland LC, Rintala-Maki ND, White RD
and Morin CD: RNA binding motif (RBM) proteins: A novel family of
apoptosis modulators? J Cell Biochem. 94:5–24. 2005. View Article : Google Scholar
|
|
24
|
Shi C and Zhang Z: miR-761 inhibits tumor
progression by targeting MSI1 in ovarian carcinoma. Tumour Biol.
37:5437–5443. 2016. View Article : Google Scholar
|
|
25
|
Akasaka Y, Saikawa Y, Fujita K, Kubota T,
Ishikawa Y, Fujimoto A, Ishii T, Okano H and Kitajima M: Expression
of a candidate marker for progenitor cells, Musashi-1, in the
prolif-erative regions of human antrum and its decreased expression
in intestinal metaplasia. Histopathology. 47:348–356. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dominguez-Sola D, Ying CY, Grandori C,
Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J and
Dalla-Favera R: Non-transcriptional control of DNA replication by
c-Myc. Nature. 448:445–451. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Y, Cheng J, Xie D, Ding X, Hou H,
Chen X, Er P, Zhang F, Zhao L, Yuan Z, et al: NS1-binding protein
radiosensitizes esophageal squamous cell carcinoma by
transcriptionally suppressing c-Myc. Cancer Commun (Lond).
38:332018. View Article : Google Scholar
|
|
28
|
Mesquita FP, Pinto LC, Soares BM, de Sousa
Portilho AJ, da Silva EL, de Farias Ramos IN, Khayat AS,
Moreira-Nunes CA, Bezerra MM, de Lucas Chazin E, et al: Small
benzothiazole molecule induces apoptosis and prevents metastasis
through DNA interaction and c-MYC gene supression in diffuse-type
gastric adenocarcinoma cell line. Chem Biol Interact. 294:118–127.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Redell MS and Tweardy DJ: Targeting
transcription factors for cancer therapy. Curr Pharm Des.
11:2873–2887. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Deepak Roshan VG, Sinto MS, Thomas S and
Kannan S: Cyclin D1 overexpression associated with activation of
STAT3 in oral carcinoma patients from South India. J Cancer Res
Ther. 14:403–408. 2018.PubMed/NCBI
|
|
32
|
Gkouveris I, Nikitakis N, Avgoustidis D,
Karanikou M, Rassidakis G and Sklavounou A: ERK1/2, JNK and STAT3
activation and correlation with tumor differentiation in oral SCC.
Histol Histopathol. 32:1065–1076. 2017.PubMed/NCBI
|
|
33
|
Li R, You S, Hu Z, Chen ZG, Sica GL, Khuri
FR, Curran WJ, Shin DM and Deng X: Inhibition of STAT3 by
niclosamide synergizes with erlotinib against head and neck cancer.
PLoS One. 8:e746702013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun S and Zhang Z: Patient-derived
xenograft platform of OSCC: A renewable human bio-bank for
preclinical cancer research and a new co-clinical model for
treatment optimization. Front Med. 10:104–110. 2016. View Article : Google Scholar : PubMed/NCBI
|
